New PAHO report shows NCDs continue as main cause of death and disability in the Americas, warns countries to prepare health systems for rapidly aging population

Cristina Mitchell

28 Jun 2024

View the full post Norovirus is dominant causative agent of gastro outbreak on NOW Grenada.

Vallabh and her husband, Eric Minikel, scientists at the Broad Institute, have been racing to develop a treatment for prion disease, a rare form of neurodegeneration that killed her mother at age 51 and would, if left untreated, likely kill Vallabh as well. It’s an insidious disease. Although it can have several causes, in her case, a single genetic misspelling will lead neurons to produce misfolded versions of otherwise workaday proteins called prions. These mutant prions jump cell to cell, like viruses, misfolding other prions they touch and forming toxic, neuron-killing chains.

So why not use CRISPR to repair or remove the mutant gene?

Continue to STAT+ to read the full story…

The agent received previous approval for adults with relapsed or refractory diffuse large B-cell lymphoma after two previous lines of therapy.FDA based accelerated approval on results from the open-label EPCORE NHL-1

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Read on today for some exclusive hiring news and a retraction of a high-profile paper on cancer detection.

Read the rest…

Vincent and the Grenadines will initiate “Hope for the Future” – a significant gathering of key stakeholders in each territory to underscore the need for comprehensive school nutrition policies that regulate the sale and marketing of ultra processed products from school settings and are supported by octagonal front of package warning label to help school communities easily identify foods which should not be available in school settings. This is an essential strategy for building healthy and resilient communities. Notably, nearly 40 youth health advocates are leading the charge across participating countries.

Youth in Antigua and Barbuda, Grenada, Montserrat, St. Kitts and Nevis and Trinidad and Tobago will be hosting related activities to spotlight the issue. These events will serve as a compelling reminder to local and regional leaders of their commitment to implementing health-protecting strategies, including evidence-based healthy food policies. In line with the food and security thematic area of the Conference of Heads of Government of CARICOM, youth hope that healthy school nutrition policies will be considered and urgently implemented to ensure healthy school food environments are prioritized.

In February 2024, the Healthy Caribbean Coalition (HCC) and Healthy Caribbean Youth (HCY) organized “Caribbean Youth Voices in Health Advocacy Spaces – Healthy Food Policy Action,” in partnership with the Jamaica Youth Advocacy Network (JYAN), the Heart Foundation of Jamaica (HFJ), The Heart and Stroke Foundation of Barbados (HSFB), and UNICEF Jamaica. This three-day health policy-focused youth meeting added momentum to the efforts aimed at empowering the region’s youth to advocate for the implementation of Healthy Food Policies, including octagonal front-of-package nutrition warning labeling and restricting the availability and marketing of unhealthy products in school settings. Over 50 young people attended this event.

All children in the Caribbean deserve to learn and grow in healthy school environments that are not inundated with ultraprocessed products. It has been 17 years since the region’s leaders unified their vision for a healthier Caribbean through the Port of Spain Declaration. Now, it is time for them to revisit previous commitments, including healthier school food environments, #actonfacts and walk the talk for better nutrition in schools. They have the support of the region’s youth.
Danielle Walwyn
Advocacy Officer, HCC and Lead, Healthy Caribbean Youth (youth arm of the HCC)

The post Hope for the Future appeared first on Healthy Caribbean Coalition.

he Society Annual Scientific Meeting. “However, not all patients have an adequate response to their initial triptan.”Bodhani and colleagues aimed to assess the burden of

Guyana is now boasting a significant number of therapists, resulting in several countries being eager to learn about the strategy to do so, according to Director of Disability and Rehabilitation Services, Dr. Ariane Mangar. “People want what we have and they want to also learn how we were able to [achieve] such a remarkable feat ...

So grab that cup of stimulation and get started. Our flavor today is mocha hazelnut, for those tracking our habits. Now, though, the time has come to get busy. So please grab your own cup and dig in to the items of interest assembled below. We hope you have a wonderful day, and please do keep in touch. …

For the second time, the U.S. Food and Drug Administration has declined to approve an AbbVie therapy for patients with Parkinson’s disease due to problems at a third-party manufacturer, Reuters writes. The company maintained that the agency had not identified issues with the therapy’s safety or efficacy and did not request additional trials. The therapy is a version of carbidopa-levodopa, the standard of care for the disease. It is administered subcutaneously, or under the skin, through an infusion pump in order to improve patients’ motor functions. If approved, analysts estimate $619.67 million in sales for ABBV-951 in 2026, according to LSEG data.

U.S. Sen. Jacky Rosen (D-Nev.) wants the U.S. Department of Health and Human Services to investigate why a low-cost generic cancer drug is not widely available to patients, The Hill reports. In a letter sent to the agency, Rosen questioned why Medicare patients pay $3,000 a month for abiraterone, a generic oral drug used as part of prostate cancer treatment, when a version that costs $171 is also on the market. The drug is sold by CivicaScript, a nonprofit that works with manufacturers to develop a drug and then partners with insurers, pharmacies, and pharmacy benefit managers to sell it to patients at a fraction of the price it would cost otherwise.

Continue to STAT+ to read the full story…